|The ATP6V1E2 n/a (Catalog #MBS6008151) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The ATP6V1E2 (V-type Proton ATPase Subunit E 2, V-ATPase Subunit E 2, Vacuolar Proton Pump Subunit E 2, ATP6E1, ATP6EL2, ATP6V1EL2) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s ATP6V1E2 can be used in a range of immunoassay formats including, but not limited to, Immunoprecipitation (IP).
Suitable for use in Immunoprecipitation. Researchers should empirically determine the suitability of the ATP6V1E2 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. The amino acid sequence is listed below:
MALSDVDVKK QIKHMMAFIE QEANEKAEEI DAKAEEEFNI EKGRLVQTQR LKIMEYYEKK EKQIEQQKKI LMSTMRNQAR LKVLRARNDL ISDLLSEAKL RLSRIVEDPE VYQGLLDKLV LQGLLRLLEP VMIVRCRPQD LLLVEAAVQK AIPEYMTISQ KHVEVQIDKE AYLAVNAAGG VEVYSGNQRI KVSNTLESRL DLSAKQKMPE IRMALFGANT NRKFFI.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Subunit of the peripheral V1 complex of vacuolar ATPase essential for assembly or catalytic function. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells. This isoform is essential for energy coupling involved in acidification of acrosome.
Immunogen: Full length human ATP6V1E2, aa1-226 (NP_542384.1). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ATP6V1E2 are readily searchable from our website. Different antibodies against the same target such as ATP6V1E2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.